Danavish Glimepiride+Metformin+Voglibose 1mg/500mg/0.2mg Tablet SR
Danavish Glimepiride+Metformin+Voglibose 1mg/500mg/0.2mg Tablet SR belongs to a category of medicines known as anti-diabetic drugs. It is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Danavish Glimepiride+Metformin+Voglibose 1mg/500mg/0.2mg Tablet SR
Basic Information
Important information about this medicine
About This Medicine
General information about this product
Danavish Glimepiride+Metformin+Voglibose 1mg/500mg/0.2mg Tablet SR belongs to a category of medicines known as anti-diabetic drugs. It is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Danavish Glimepiride+Metformin+Voglibose 1mg/500mg/0.2mg Tablet SR belongs to a category of medicines known as anti-diabetic drugs. It is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take Danavish Glimepiride+Metformin+Voglibose 1mg/500mg/0.2mg Tablet SR with or immediately before meals. Take it regularly at the same time each day to get the most benefit. Your doctor will decide what dose is best for you, and this may change from time to time depending on how it is working according to your blood sugar levels.
Keep taking this medicine, even if you feel well or your blood sugar levels are controlled. If you stop it without consulting your doctor, your blood sugar levels could rise and put you at risk of kidney damage, blindness, nerve problems, and loss of limbs. Remember that it is only part of a treatment program that should also include a healthy diet, regular exercise, and weight reduction as advised by your doctor. Your lifestyle plays a big part in controlling diabetes.
Common side effects of Danavish Glimepiride+Metformin+Voglibose 1mg/500mg/0.2mg Tablet SR are nausea, vomiting, abdominal pain, and loss of appetite. Make sure you recognize the signs of low blood glucose levels, such as sweating, dizziness, headache, and shaking, and know how to deal with them. To prevent this, it’s important to have regular meals and always carry a fast-acting source of glucose, such as sugary food or fruit juice, with you.
Drinking alcohol can also increase your risk of low blood sugar levels and should be avoided. Other side effects that may be seen on taking this medicine include taste changes, nausea, diarrhea, stomach pain, headache, edema (swelling), blurred vision, bone fracture, and upper respiratory tract infection. Some people may find that they put on weight with this medicine.
You should not take Danavish Glimepiride+Metformin+Voglibose 1mg/500mg/0.2mg Tablet SR if you have type 1 diabetes mellitus, if you have diabetic ketoacidosis (high levels of acid in your blood), or if you have severe kidney or liver disease. Before taking this medicine, tell your doctor if you have ever had heart disease, as it may not be suitable. Pregnant or breastfeeding women should also consult their doctor before taking it. Your blood sugar levels should be checked regularly, and your doctor may also advise blood tests to monitor your blood cell counts and liver function.
03Uses
Treatment of Type 2 diabetes mellitus
04How To Use
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Danavish Glimepiride+Metformin+Voglibose 1mg/500mg/0.2mg Tablet SR is to be taken with food.
05How It Works
Danavish Glimepiride+Metformin+Voglibose 1mg/500mg/0.2mg Tablet SR is a combination of three antidiabetic medicines: glimepiride, metformin, and voglibose. They work by different mechanisms to provide better control of blood sugar when single or dual therapy is not effective. Glimepiride is a sulfonylurea that works by increasing the amount of insulin released by the pancreas to lower the blood glucose. Metformin is a biguanide that lowers glucose production in the liver, delays glucose absorption from the intestines, and increases the body’s sensitivity to insulin. Voglibose is an alpha-glucosidase inhibitor that prevents the breakdown of complex sugars into simple sugars such as glucose. This prevents the blood glucose levels from rising to very high levels after meals.
06What If You Miss A Dose?
Q: What if you forget to take Danavish Tablet SR?
A: If you miss a dose of Danavish Glimepiride+Metformin+Voglibose 1mg/500mg/0.2mg Tablet SR, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
07Benefits
In Treatment of Type 2 diabetes mellitus
Danavish Glimepiride+Metformin+Voglibose 1mg/500mg/0.2mg Tablet SR is a medicine that helps to control high blood glucose (sugar) levels. It helps to slow down the breaking down of food in our intestine to simple glucose (sugar), thereby decreasing the rise in blood glucose levels after meals. It also helps get rid of extra glucose from your body through urine. Lowering blood glucose levels is an essential part of managing diabetes. If you can control the level, you will reduce the risk of getting any of the serious complications of diabetes such as kidney damage, eye damage, nerve problems and loss of limbs. Danavish Glimepiride+Metformin+Voglibose 1mg/500mg/0.2mg Tablet SR will reduce the risk of dying from cardiovascular disease if you have type 2 diabetes and already have cardiovascular disease. Taking this medicine regularly along with proper diet and exercise will help you live a normal, healthy life. You should keep using it for as long as it is prescribed because it is protecting your future health.
08Side Effects
Nausea
Diarrhea
Abdominal pain
Hypoglycemia (low blood glucose level)
Loss of appetite
09Safety Information
Alcohol:UNSAFE
It is unsafe to consume alcohol with Danavish Glimepiride+Metformin+Voglibose 1mg/500mg/0.2mg Tablet SR.
Pregnancy:CONSULT YOUR DOCTOR
Danavish Glimepiride+Metformin+Voglibose 1mg/500mg/0.2mg Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding:CONSULT YOUR DOCTOR
Danavish Glimepiride+Metformin+Voglibose 1mg/500mg/0.2mg Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Driving:CAUTION
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Kidney:UNSAFE
Danavish Glimepiride+Metformin+Voglibose 1mg/500mg/0.2mg Tablet SR is probably unsafe to use in patients with kidney disease and should be avoided. Please consult your doctor.Use of Danavish Glimepiride+Metformin+Voglibose 1mg/500mg/0.2mg Tablet SR is, however, not recommended in patients with severe kidney disease.
Liver:CAUTION
Danavish Glimepiride+Metformin+Voglibose 1mg/500mg/0.2mg Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Danavish Glimepiride+Metformin+Voglibose 1mg/500mg/0.2mg Tablet SR may be needed. Please consult your doctor.Danavish Glimepiride+Metformin+Voglibose 1mg/500mg/0.2mg Tablet SR is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
10Drug Tips
Danavish Glimepiride+Metformin+Voglibose 1mg/500mg/0.2mg Tablet SR can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines or alcohol, or if you delay or miss a meal. Carry a sugar source with you for immediate relief.
Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Individuals with severe renal or hepatic impairment should not take Danavish Glimepiride+Metformin+Voglibose 1mg/500mg/0.2mg Tablet SR.
This medicine works best when used along with proper diet and exercise.
References
Sources and references
Glimepiride [FDA Label]. Bridgewater, New Jersey: Sanofi-Aventis U.S. LLC.; 2009. [Accessed 08 Apr. 2019] (online) Available from: View
Metformin hydrochloride [Prescribing Information]. Princeton, New Jersey: Bristol-Myers Squibb Company; 2008. [Accessed 08 Apr. 2019] (online) Available form: View
Dabhi AS, Bhatt NR, Shah MJ. Voglibose: An Alpha Glucosidase Inhibitor. J Clin Diagn Res. 2013;7(12):3023-7. [Accessed 08 Apr. 2019] (online) Available from: View
Glimepiride+Metformin+Voglibose [Product Monograph]. Punjab, India: Centaur Pharmaceuticals Pvt. Ltd.; 2018. [Accessed 25 Oct. 2021] (online) Available from: View
Metformin Hydrochloride (Prolonged Release), Voglibose & Glimepiride [Patient Information Sheet]. Ahmedabad, Gujarat: Torrent Pharmaceuticals Ltd.; 2015. [Accessed 28th Sept. 2023] (online) Available from: View
